Four Blockbuster Drugs Whose Sales Could Easily Double

The holy grail of the drug development process is uncovering a drug capable of blockbuster sales. In layman's terms, we're talking about $1 billion or more in annual sales.

As you might imagine, the deck is already stacked against drug developers even getting a drug approved by the Food and Drug Administration. Medscape suggests that just one in 5,000 to 10,000 preclinical compounds will actually make it to pharmacy shelves. Of those drugs that are approved, a vast majority will not generate $1 billion or more in annual sales.

Help employers find you! Check out all the jobs and post your resume.

Back to news